What is included in inhibitor testing for factor XIII (FXIII) deficiency?

Updated: Mar 09, 2021
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: Perumal Thiagarajan, MD  more...
  • Print

Repeat the urea solubility test with mixtures containing varying proportions of patient and normal plasma to differentiate between a deficiency or an inhibitor as the cause of a positive result; serum may be substituted for plasma in the test

Semiquantitation of the susceptibility of the fibrin clot to fibrinolysis can be obtained by adding iodine-125-labeled fibrinogen, tissue plasminogen activator, thrombin, and Ca2 + to the patient's plasma, with measurement of the time to 50% clot lysis

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!